Pharma News

Quemliclustat plus gemcitabine and nab-paclitaxel chemotherapy outperformed median OS benchmarks in patients with metastatic PDAC.

Researchers at the Medical University of South Carolina have made a breakthrough in pain management.

CTO East Coast 2025: Global oncology cell therapy market to hit $25bn by 2031

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with advanced pulmonary arterial hypertension, according to a press release from...

China's Everest Medicines Unveils Positive Preclinical Validations of In Vivo CAR-T Program

Harmony Biosciences Holdings Inc. (NASDAQ:HRMY) is one of the most undervalued small-cap stocks to buy according to analysts.

Klotho Neurosciences announced that its novel therapy KLTO-202, also known as s-KL-AAV.myo, for the treatment of Amyotrophic Lateral Sclerosis (ALS) has received Orphan

Trump’s 200% tariff threat could send shockwaves through pharma supply chains

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal.

Artelo Biosciences’ ART12.11 Shows Promising Antidepressant Effects in Preclinical Study

Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025

Cyclacel Pharmaceuticals (CYCC) highlighted a publication from independent investigators titled, “DNAJ-PKAc fusion heightens PLK1 inhibitor sensitivity in fibrolamellar carcinoma,” publish...